Reaching for a diet soda or artificially sweetened ... lead author on the recent xylitol and erythritol studies. The FDA, however, has approved six artificial sweeteners and considers them ...

Spravato’s rapid growth: Spravato blazed a trail in 2019 as the first new major depression treatment to win FDA approval in more than three decades. The drug is related to ketamine, which is a ...

The FDA has approved esketamine ... treatment-resistant depression. This approval applies to individuals who have had an inadequate response to at least two oral antidepressants. The announcement was ...

The FDA also gave its nod to Bristol Myers Squibb’s Cobenfy (xanomeline and trospium chloride), the first new class of antischizophrenia drug to be approved in decades. Roughly one-third of last ...

The widely-used drug was approved by the Food and Drug Administration 25 years ago. However, the FDA has eased restrictions on the drug. U.S. District Judge Matthew Kacsmaryk, who was appointed by ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration ... Spravato is the first and only approved monotherapy for adults with refractory major depressive disorder.

The U.S. Food and Drug Administration (FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with treatment ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

The US Food and Drug Administration (FDA) has expanded the approval for Johnson & Johnson’s nasal spray Spravato to allow its standalone use in patients with depression, the company said on Jan 21.

Spravato's long road to rapid growth Spravato blazed a new trail in 2019 as the first new major depression treatment to win FDA approval in more than three decades. The drug is related to ketamine ...

21, 2025 -- The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed. The drug ...

Jan 21 (Reuters) - The U.S. Food and Drug Administration expanded approval ... Future of Healthcategory US FDA approves Vertex's non-opioid painkiller 12:16 AM UTC Future of Healthcategory UK ...